Test fluid dosing during laparoscopic abdominal surgery
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a “fluid challenge” approach during surgery to better control your body’s fluid level. It may help guide how much fluid is safely given during longer laparoscopic abdominal operations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a written consent form to join
- You are between 18 and 85 years old (inclusive)
- Your surgery is laparoscopic abdominal surgery that lasts at least 90 minutes
- You are generally medically stable (ASA class I to III)
- If you could become pregnant, you agree to reliable birth control or have a negative pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects fluid from the uterus during gynecologic surgery to study cells and molecules, which may help understand how women's health conditions develop.
This trial tests whether adding a protein called albumin to standard fluids given during surgery helps patients with advanced cancer in the abdomen (from the ovaries, uterus, or digestive system) recover better. You would receive either the usual fluids or fluids plus albumin during your operation.
This trial tests a quick breathing maneuver during surgery to see if it can guide how much fluid to give, aiming to improve recovery and stability.
This trial tests a new platform that looks at fluid from drains after abdominal or pelvic surgery to see if it can help detect complications early. It may help doctors monitor your recovery more closely.
This trial tests whether carefully controlling the amount of fluids given during and after liver surgery can improve recovery. It may help patients avoid complications and have better outcomes after their operation.
This study tests a special IV fluid called Volulyte 6% given before, during, and after major abdominal surgery. The goal is to see if it is safe and helps protect the heart and blood vessels in people who are at higher risk of heart problems.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.